ANCA-Associated Vasculitis (AAV)

Episodes 1-4 of 4

• 

  RestartResume

  Call to Action: Utilizing Avacopan to Improve AAV Care

  RestartResume

  Call to Action: Utilizing Avacopan to Improve AAV Care

  CME/CE

  Call to Action: Utilizing Avacopan to Improve AAV Care

  • 

    

    Stephen McAdoo, MD

• 

  RestartResume

  Elevating AAV Care: Expert Strategies for Optimal Patient Outcomes

  RestartResume

  Elevating AAV Care: Expert Strategies for Optimal Patient Outcomes

  ANCA-Associated Vasculitis (AAV)

  Elevating AAV Care: Expert Strategies for Optimal Patient Outcomes

  • 

    

    Annette Bruchfeld, MD, PhD

  • 

    

    Stephen McAdoo, MD

  • 

    

    Andreas Kronbichler, MD

• 

  RestartResume

  Incorporating Targeted Therapies in Treatment Planning for AAV

  RestartResume

  Incorporating Targeted Therapies in Treatment Planning for AAV

  CME/CE

  Incorporating Targeted Therapies in Treatment Planning for AAV

  • 

    

    David Jayne, MD

  • 

    

    Bernhard Hellmich, MD

• 

  RestartResume

  Case-Based Management of AAV

  RestartResume

  Case-Based Management of AAV

  CME/CE

  Case-Based Management of AAV

  • 

    

    David Jayne, MD

  • 

    

    Annette Bruchfeld, MD, PhD